钆塞酸增强MRI减影图像:对肝细胞癌高危患者局灶性肝脏病变诊断效能的影响
回顾性分析227例慢性肝炎或肝硬化患者249个肝脏结节,比较钆塞酸增强MRI减影图像与视觉评估对动脉期富血供的检出率及诊断HCC的效能。减影图像检出动脉期富血供的敏感度高于视觉评估(89.2% vs 72.4%,p<0.001);联合减影与视觉增强模式诊断HCC的敏感度从76.5%升至87.5%(p<0.001),特异度从80.9%降至78.1%(p=0.332)。
要点
- 减影图像检出肝脏病变动脉期富血供的敏感度高于视觉评估(89.2% vs 72.4%,p<0.001)。
- 联合减影图像与视觉增强模式诊断HCC,敏感度从76.5%升至87.5%,特异度从80.9%降至78.1%。
- 各亚组(HCC与非HCC、病灶≤3cm与>3cm、1.5T与3T)均观察到减影图像检出动脉期富血供的相同趋势。
核心结论
- 加用减影图像并考虑视觉增强模式,可通过提高动脉期富血供的检出率来提升诊断HCC的敏感度。
研究设计与样本
- 回顾性分析233例慢性肝炎或肝硬化患者(187男、46女,平均年龄55.2岁)术前钆塞酸增强MRI与手术切除资料,最终分析227例患者249个结节(215个HCC、27个胆管癌、7个混合型HCC-胆管癌);以病理为参考标准,比较减影图像与视觉评估。
诊断标准与关键数值
- 减影图像检出所有肝脏病变动脉期富血供的敏感度为89.2%,视觉评估为72.4%(p<0.001);按美国肝病研究学会指南诊断HCC,联合减影图像与视觉增强模式的敏感度为87.5%、特异度为78.1%,仅视觉评估的敏感度为76.5%、特异度为80.9%(敏感度比较p<0.001,特异度比较p=0.332)。
临床应用与阅片要点
- 阅片时可加用减影图像辅助判断动脉期富血供,并结合视觉增强模式综合诊断HCC;原文结论为加用减影图像可提高诊断HCC的敏感度。
局限性
- 原文为回顾性分析。
- 排除6例图像质量不符合诊断要求的患者后进行分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to evaluate the effect of subtraction images of gadoxetic acid-enhanced MRI on the image interpretation of focal hepatic lesions in patients at risk for hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: We retrospectively analyzed 255 malignant nodules from 233 patients with chronic hepatitis or liver cirrhosis (187 men and 46 women; mean age, 55.2 years) who underwent preoperative gadoxetic acid-enhanced MRI and surgical resection. We compared the detection rate of arterial hypervascularity on visual assessment with that of subtraction images. Subgroup analysis was performed according to the pathologic profile of the lesion (HCC vs non-HCC), the lesion size (≤ 3 vs > 3 cm), and the MRI technique (1.5 vs 3 T). We assessed the effect of subtraction images in diagnosing HCC according to the American Association for the Study of Liver Diseases guidelines compared with that of visual assessment.
RESULTS: After excluding six patients whose images were not of nondiagnostic quality, 249 nodules (215 HCCs, 27 cholangiocarcinomas, and seven combined HCC and cholangiocarcinomas) from 227 patients were analyzed. Subtraction images more sensitively detected the arterial hypervascularity of all of the hepatic lesions than did visual assessment (sensitivity, 89.2% vs 72.4%; p < 0.001). In all of the subgroup analyses, the same tendency was observed (p = 0.001-0.145). Compared with visual assessment only, arterial hypervascularity determined by both subtraction images and the visual enhancement patterns increased sensitivity from 76.5% to 87.5% (p < 0.001) in diagnosing HCCs, with a minimal decrease in specificity from 80.9% to 78.1% (p = 0.332).
CONCLUSION: Adding subtraction images with consideration of visual enhancement patterns can enhance the sensitivity in diagnosing HCC by enhancing the detection of arterial hypervascularity.
引用
- Choi SH, Kim SY, Lee SS, et al. Subtraction Images of Gadoxetic Acid-Enhanced MRI: Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma. AJR Am J Roentgenol. 2017. PMID: 28609188. doi:10.2214/AJR.16.17211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。